DiaMedica Therapeutics Inc. (DMAC) 追踪市盈率为负值 -8.8, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 追踪盈利收益率为 -11.32%.
本页证实的标准:
SharesGrow 综合评分： 51/100 其中 3/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -4.7 | -0.27 | 8.36 | 0.00 | - |
| 2017 | -6.8 | -0.13 | 36.25 | 0.00 | - |
| 2018 | -3.9 | -1.41 | 1.32 | 45.07 | - |
| 2019 | -5.5 | -0.27 | 7.63 | 0.00 | - |
| 2020 | -12.9 | 1.05 | 6.11 | 0.00 | - |
| 2021 | -5.7 | 0.34 | 1.76 | 0.00 | - |
| 2022 | -3.1 | 0.15 | 1.31 | 0.00 | - |
| 2023 | -4.8 | -0.31 | 1.81 | 0.00 | - |
| 2024 | -9.0 | 0.00 | 5.39 | 0.00 | - |
| 2025 | -11.4 | -0.68 | 6.66 | 0.00 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-0.47 | $0.00 | $-2.22M | - |
| 2017 | $-0.72 | $0.00 | $-4.26M | - |
| 2018 | $-0.74 | $500K | $-5.73M | -1146.8% |
| 2019 | $-0.89 | $0.00 | $-10.65M | - |
| 2020 | $-0.78 | $0.00 | $-12.29M | - |
| 2021 | $-0.65 | $0.00 | $-13.59M | - |
| 2022 | $-0.52 | $0.00 | $-13.68M | - |
| 2023 | $-0.60 | $0.00 | $-19.38M | - |
| 2024 | $-0.60 | $0.00 | $-24.44M | - |
| 2025 | $-0.70 | $0.00 | $-32.77M | - |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.76 | $-0.92 – $-0.60 | $54M | $54M – $54M | 3 |
| 2027 | $-0.88 | $-0.88 – $-0.88 | $2.79M | $2.79M – $2.79M | 3 |
| 2028 | $-0.89 | $-1.19 – $-0.33 | $14.05M | $14.01M – $14.08M | 3 |
| 2029 | $-0.67 | $-0.67 – $-0.67 | $39.6M | $39.6M – $39.6M | 1 |
| 2030 | $-0.33 | $-0.33 – $-0.33 | $117.78M | $117.78M – $117.78M | 1 |
